Dihydroartemisinin and Piperaquine Exporter, Manufacturer and Global Supplier in India

Dihydroartemisinin and Piperaquine Exporter, as a reliablewe ensure that this medicine is manufactured under stringent quality standards, following WHO GMP norms and international pharmacopeia guidelines. Dihydroartemisinin and Piperaquine Tablet is a trusted combination medication widely used in the treatment of uncomplicated malaria, particularly cases caused by Plasmodium falciparum. This fixed-dose therapy combines the rapid parasite-clearing action of dihydroartemisinin with the long-lasting protective effect of piperaquine, making it one of the most effective antimalarial combinations recommended by global health authorities.

Composition and Mechanism

• Dihydroartemisinin: A fast-acting derivative of artemisinin that kills malaria parasites quickly, reducing fever and parasitic load.

• Piperaquine: A long-acting antimalarial agent that helps prevent recurrence by maintaining blood levels for weeks.

The synergy of these two components ensures effective parasite clearance and lowers the risk of resistance development. Trusted Dihydroartemisinin and Piperaquine Exporters supply this product globally to meet urgent malaria treatment needs.

Uses of Dihydroartemisinin and Piperaquine Tablet

• Treatment of uncomplicated Plasmodium falciparum malaria.

• Used in areas where multi-drug resistant strains are prevalent.

• May be recommended as part of national malaria eradication programs.

For healthcare providers and procurement agencies, working with a reliable Dihydroartemisinin and Piperaquine Exporter ensures consistent access to high-quality medication that meets global treatment standards.

Precautions

Before prescribing or consuming this tablet, several precautions must be considered:

• Patients with a history of hypersensitivity to artemisinin derivatives or piperaquine should avoid its use.

• Should be used cautiously in individuals with a history of heart rhythm disorders, as piperaquine may cause QT prolongation.

• Not recommended for children under 6 months or patients weighing less than 5 kg.

• Pregnant women should only take it if the potential benefits outweigh the risks, under medical supervision.

• Drug interactions with antiretrovirals, antibiotics, or cardiac medicines should be carefully evaluated.

Healthcare professionals often rely on a qualified Dihydroartemisinin and Piperaquine Exporter to ensure safe, batch-tested medicines that adhere to strict pharmacological safety profiles.

Possible Side Effects

While generally well-tolerated, some patients may experience:

• Nausea, vomiting, or abdominal discomfort

• Headache and dizziness

• Loss of appetite

• Fatigue or weakness

• Rare but serious: heart rhythm disturbances (QT prolongation), allergic reactions

As an experienced Dihydroartemisinin and Piperaquine Exporter, we emphasize providing authentic products with accurate labeling and patient information leaflets to minimize risks associated with self-medication.

Why Choose Us as Your Dihydroartemisinin and Piperaquine Exporter?

• WHO GMP & ISO certified manufacturing facilities.

• Strict compliance with international pharmacopeia standards.

• Affordable pricing with guaranteed supply chain reliability.

• Custom packaging and labeling for different markets.

• Global shipping support for hospitals, distributors, NGOs, and government tenders.

Our commitment as a trusted Dihydroartemisinin and Piperaquine Exporter is not just to deliver medicine but also to contribute to global malaria control initiatives by ensuring timely access to life-saving treatment.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Dihydroartemisinin and Piperaquine Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.